Longterm Safety, Efficacy, and Inhibition of Structural Damage Progression Over 5 Years of Treatment With Abatacept in Patients With Rheumatoid Arthritis in the Abatacept in Inadequate Responders to Methotrexate Trial
Journal of Rheumatology - Canada
doi 10.3899/jrheum.130263
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2014
Authors
Publisher
The Journal of Rheumatology